OPKO Health, Inc. Goodwill, Gross
OPKO Health, Inc. (OPK) had Goodwill, Gross of $522.31 million as of 2025-12-31, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillGross · last filed 2026-08-28
- 2025-12-31: Goodwill, Gross $522.31M; Goodwill, Gross as first filed $567.27M.
- 2024-12-31: Goodwill, Gross $636.28M.
- 2023-12-31: Goodwill, Gross $633.87M; Goodwill, Gross as first filed $636.28M.
- 2022-12-31: Goodwill, Gross $633.87M.
| Period end | Goodwill, Gross | Goodwill, Gross as first filed |
|---|---|---|
| 2025-12-31 | $522.31M 10-Q/A · filed 2026-08-28 | $567.27M 10-K · filed 2026-02-26 |
| 2024-12-31 | $636.28M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $633.87M 10-K · filed 2025-03-03 | $636.28M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $633.87M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $710.41M 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |